0,4742
24-декабря-24 13:45:00
15 мин. задержка
Акции
+0,0242
+5,38%
Сегодняшний диапазон
0,4233 - 0,4794
ISIN
N/A
Источник
NASDAQ
AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina
08 ноя 2024 06:00:00 Источник Nasdaq GlobeNewswire
AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy
22 дек 2023 07:00:00 Источник Nasdaq GlobeNewswire